Advertisement
Screener

SONOMA PHARMACEUTICALS, INC. (SNOA) Proceeds from Sale of Available-for-sale Securities

SONOMA PHARMACEUTICALS, INC. Proceeds from Sale of Available-for-sale Securities

SONOMA PHARMACEUTICALS, INC. (SNOA) reported Proceeds from Sale of Available-for-sale Securities of $3.12 million for the 6-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.

Discontinued › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2012-11-08

  • SONOMA PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for the quarter ending 2012-09-30 was $0.00.
  • SONOMA PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for the quarter ending 2012-06-30 was $3.12M.
Period endProceeds from Sale of Available-for-sale Securities 3 monthProceeds from Sale of Available-for-sale Securities 6 month
2012-09-30$0.00
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-08
$3.12M
10-Q · filed 2012-11-08
2012-06-30$3.12M
10-Q/A · filed 2012-08-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Co-Diagnostics, Inc. (CODX)United States$0.007B-0.32
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26